{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "GABATHER AB (PUBL) SK-,44", "longName": "Gabather AB (publ)", "messageBoardId": "finmb_272213744", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 7.7994423, "regularMarketPrice": 0.387, "marketState": "REGULAR", "sharesOutstanding": 14690200, "fiftyDayAverage": 0.28224, "fiftyDayAverageChange": 0.10475999, "fiftyDayAverageChangePercent": 0.37117344, "twoHundredDayAverage": 0.3512, "twoHundredDayAverageChange": 0.03579998, "twoHundredDayAverageChangePercent": 0.10193616, "marketCap": 6124429, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1597298400000, "priceHint": 4, "regularMarketChange": 0.027999997, "regularMarketTime": 1683892037, "regularMarketDayHigh": 0.387, "regularMarketDayRange": "0.369 - 0.387", "regularMarketDayLow": 0.369, "regularMarketVolume": 183, "regularMarketPreviousClose": 0.359, "bid": 0.387, "ask": 0.448, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.375, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.15949999, "fiftyTwoWeekLowChangePercent": 0.7010988, "fiftyTwoWeekRange": "0.2275 - 0.56", "fiftyTwoWeekHighChange": -0.17300001, "fiftyTwoWeekHighChangePercent": -0.30892858, "fiftyTwoWeekLow": 0.2275, "fiftyTwoWeekHigh": 0.56, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.08, "symbol": "5J2.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Forskargatan 20J", "address2": "Byggn 215 N", "city": "S\u00f6dert\u00e4lje", "zip": "151 36", "country": "Sweden", "website": "https://www.gabather.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Gabather AB (publ) develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company was incorporated in 2014 and is based in S\u00f6dert\u00e4lje Sweden.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael-Robin  Witt", "title": "Chief Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Christine  Ryan", "title": "VP of Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}